Prevalence, Risk Factors and Complications of Diabetes Insipidus in the Republic of Uzbekistan

Authors

  • Z.Yu. Khalimova Republican Specialized Scientific and Practical Medical Centre of Endocrinology of Ministry of Healthcare of Republic of Uzbekistan Tashkent Pediatric Medical Institute, Department of Endocrinology, Pediatric Endocrinology, Tashkent, Uzbekistan
  • Yu.M. Urmanova Republican Specialized Scientific and Practical Medical Centre of Endocrinology of Ministry of Healthcare of Republic of Uzbekistan Tashkent Pediatric Medical Institute, Department of Endocrinology, Pediatric Endocrinology, Tashkent, Uzbekistan
  • D.A. Aliyeva Republican Specialized Scientific and Practical Medical Centre of Endocrinology of Ministry of Healthcare of Republic of Uzbekistan Tashkent Pediatric Medical Institute, Department of Endocrinology, Pediatric Endocrinology, Tashkent, Uzbekistan
  • M.M. Karimova Republican Specialized Scientific and Practical Medical Centre of Endocrinology of Ministry of Healthcare of Republic of Uzbekistan Tashkent Pediatric Medical Institute, Department of Endocrinology, Pediatric Endocrinology, Tashkent, Uzbekistan
  • Kh.K. Nasyrova Republican Specialized Scientific and Practical Medical Centre of Endocrinology of Ministry of Healthcare of Republic of Uzbekistan Tashkent Pediatric Medical Institute, Department of Endocrinology, Pediatric Endocrinology, Tashkent, Uzbekistan
  • F.S. Khodjayeva Republican Specialized Scientific and Practical Medical Centre of Endocrinology of Ministry of Healthcare of Republic of Uzbekistan Tashkent Pediatric Medical Institute, Department of Endocrinology, Pediatric Endocrinology, Tashkent, Uzbekistan
  • Sh.A. Bobokhodjayeva Republican Specialized Scientific and Practical Medical Centre of Endocrinology of Ministry of Healthcare of Republic of Uzbekistan Tashkent Pediatric Medical Institute, Department of Endocrinology, Pediatric Endocrinology, Tashkent, Uzbekistan

DOI:

https://doi.org/10.22141/2224-0721.7.55.2013.84675

Keywords:

diabetes insipidus, prevalence, complications

Abstract

Despite the fact that diabetes insipidus (DI) is a rare independent disorder, there are many publications on this subject in the contemporary literature. Interest to the problem of DI is due to the fact that the syndrome of diabetes insipidus can be both a separate disease (central, nephrogenic, hereditary forms) and meet with various diseases of many organs and systems, and also be a complication of neurosurgical procedures. However, in the literature there are no data on the incidence of the disease in different countries, and the prevalence of DI syndrome is shown in a number of multicenter studies of various diseases — Langerhans cell histiocytosis, head injury, pituitary adenomas, etc.

Downloads

Download data is not yet available.

References

Лавина Н.Е. Эндокринология. — М., 1999. — С. 117-131.

Марова Е.И. Нейроэндокринология. — Ярославль: ДИА-пресс, 1999. — С. 403-421.

Agha A., Thornton E., O'Kelly P. Posterior pituitary dysfunction after traumatic brain injury // J. Clin. Endocrinol. Metab. — 2004 Dec. — 89 (12). — 5987-92.

Bichet D.G. Nephrogenic diabetes insipidus // Nephrol. Ther. — 2006 Nov. — 2 (6). — 387-404.

Esteban Bueno G., Gomez Trujillo F.M. Clinical manifestations and disgnostic delay of Wolfram’s syndrome // Rev. Clin. Esp. — 2006 Jul-Aug. — 206 (7). — 332-5.

Grois N., Potschger U., Prosch H., Minkov M. et al. Risk factors for diabetes insipidus in Langerhans cell histiocytosis // Pediatr Blood Cancer. — 2006 Feb. — 46 (2). — 228-33.

Gutenberg A., Hans V., Puchner M.J., Kreutzer J. et al. Primary hypophysitis: clinical-pathological correlations // Eur. J. Endocrinol. — 2006 Jul. — 155 (1). — 101-7.

Ishikawa S.E. Nephrogenic diabetes insipidus associated with mutation of vasopressin V2 receptors and aquaporin // Nippon Rinsho. — 2002 Feb. — 60 (2). — 350.

Qureshi M., Pathak N., Pinsker R.W. Unique case of thrombotic thrombocytopenic purpura and diabetes insipidus // Proc. West Pharmacol. Soc. — 2005. — 48. — 145-7.

Kelly S.J., Delnomdedieu M., Oliverio M.I. Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly (ethylene glycol)-modified uricase // J. Am. Soc. Nephrol. — 2001 May. — 12 (5). — 1001-9.

Khanna A. Acquired nephrogenic diabetes insipidus // Semin. Nephrol. — 2006 May. — 26 (3). — 244-8.

Li Y., Shaw S., Kamsteeg E.J. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenyl cyclase activity // J. Am. Soc. Nephrol. — 2006 Apr. — 17 (4). — 920-2.

Moses A.M., Thomas D.G., Canfield M.C. Central diabetes insipidus due to cytomegalovirus infection of the hypothalamus in a patient with acquired immunodeficiency syndrome: a clinical, pathological, and immunohistochemical case study // J. Clin. Endocrinol. Metab. — 2003 Jan. — 88 (1). — 51-4.

Morimoto A., Ikushima S., Kinugawa N., Ishii E. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study // Cancer. — 2006 Aug. — 107 (3). — 613-9.

Nemergut E.C., Zuo Z., Jane J.A. Jr. Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients // J. Neurosurg. — 2005 Sep. — 103 (3). — 448-54.

Perkins R.M., Yuan C.M., Welch P.G. Dipsogenic diabetes insipidus: report of a novel treatment strategy and literature review // Clin. Exp. Nephrol. — 2006 Mar. — 10 (1). — 63-7.

Powner D.J., Boccalandro C., Alp M. Sndocrine dysfunction in patients operated on for non-pituitary intracranial tumours // Eur. J. Endocrinol. — 2006 Oct. — 155 (4). — 559-66.

Rivera J.A. Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy // Pituitary. — 2006. — 9 (1). — 35-45.

Sheehan J.M., Sheehan J.P., Douds G.L. DDAVP use in patients undergoing transsphenoidal surgery for pituitary adenomas // Acta Neurochir. (Wien). — 2006 Mar. — 148 (3). — 287-91.

Su D.H., Liao K.M., Chen H.W., Huang T.S. Hypopituitarism: a sequela of severe hypoxic encephalopathy // J. Formos. Med. Assoc. — 2006 Jul. — 105 (7). — 536-41.

Taplin C.E., Cowell C.T., Silink M. Fludrocortisone therapy in cerebral salt wasting // Pediatrics. — 2006 Dec. — 118 (6). — 1904-8.

Valentini D., Cappelli C., Mizzoni F., Noto C. et al. Erdheim-Chester disease: a non-Langerhans cell histiocytosi. A clinical-case review of the literature // Clin. Ter. — 2004 May. — 155 (5). — 205-8.

Published

2022-02-21

How to Cite

Khalimova, Z., Urmanova, Y., Aliyeva, D., Karimova, M., Nasyrova, K., Khodjayeva, F., & Bobokhodjayeva, S. (2022). Prevalence, Risk Factors and Complications of Diabetes Insipidus in the Republic of Uzbekistan. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), (7.55), 20–24. https://doi.org/10.22141/2224-0721.7.55.2013.84675

Issue

Section

Original Researches

Most read articles by the same author(s)

1 2 3 4 5 > >>